MIDRIX4-LUNG

N/A

Report date: 2024/11/20 20:00:31

Base Information

Drug NameMIDRIX4-LUNG
Drug Alias NameMIDRIX4-LUNG DCsMIDRIX4-LUNG
ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgium
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGhent University Hospital
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGhent University HospitalGhent University
Active IndicationsN/A
Inactive IndicationsCarcinoma, Non-Small-Cell Lung

Other Information

ATC CodeN/A
Related LinksN/A